This page contains McAfee (Virus & Malware Scanned) PDF Files
Biomark Diagnostics (BUX:CSE / BMKDF:OTC / 20B:FSE)
Biomark is a fascinating life sciences company that is very overlooked. It will require patience but this is one of those companies that over one to two years could produce exceptional capital gains.
This is also one of the few microcap companies that is “socially responsible” and if commercially successful, will do a LOT for humanity. Because of this, we are volunteering our time and space on MicroCap.com to help create an awareness of Biomark and their technology (scientific research).
I.) – Biomark Introduction July 1/19
II.) – Biomark to be the COVER story of CANCERS Aug 22/19
I.) July 1, 2019 – Biomark Introduction
Our complimentary introduction (research report) on Biomark – click here to Download / View the PDF >>> Biomark Diagnostics
Do You have Cancer ?
II.) August 22, 2019 – Biomark Update: Cover of CANCERS
Biomark has been chosen by editors (scientific peers) to be the September COVER story for CANCERS – one of the largest and most reputable scientific journals focused on cancer. This should move Biomark onto the radar of large pharmaceutical and diagnostic companies, along with academics around the world.
I have explained the reach of this publication along with its potential impact for investors. That update is available Here >> BioMark Cancers Update.
Disclosure / Disclaimer:
Danny Deadlock (MicroCap.com Publisher) is an independent equity analyst and has no affiliation with public companies. He receives NO compensation in ANY form from anyone – although he may be a shareholder of any public company discussed here and may also be an active buyer or seller of shares at any point in time.
Please read / reference our full legal disclaimer here: